Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Techniclone reacquires rights to Oncolym

Nov. 25, 1997

Doxil/Caelyx evaluated in phase II for advanced breast cancer

Nov. 24, 1997

Imutec licenses novel anticancer compounds from Ion

Nov. 21, 1997

New antitumor compound QM16-A described in patent literature

Nov. 21, 1997

HMR and MediGene collaborate on cancer gene therapies

Nov. 20, 1997

Safety and biochemical effects of DFMO support phase III trials for colon cancer prevention

Nov. 20, 1997

Idec begins phase I/II trial for 9-AC

Nov. 19, 1997

Banyu describes protein farnesyltransferase inhibitors

Nov. 19, 1997

Kyowa Hakko's UCT-1072M1, a new antitumor antibiotic

Nov. 19, 1997

Sch-207278: new protein farnesyltransferase inhibitor of microbial origin

Nov. 19, 1997

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...